| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 9 | 2024 | 16 | 2.650 |
Why?
|
| Pregnancy | 39 | 2026 | 1555 | 2.460 |
Why?
|
| Mifepristone | 3 | 2026 | 3 | 2.190 |
Why?
|
| Contraception, Postcoital | 3 | 2026 | 3 | 2.150 |
Why?
|
| Pre-Eclampsia | 4 | 2021 | 41 | 1.970 |
Why?
|
| Mass Screening | 9 | 2024 | 670 | 1.840 |
Why?
|
| Female | 66 | 2026 | 12193 | 1.830 |
Why?
|
| Abortion, Legal | 7 | 2015 | 8 | 1.760 |
Why?
|
| Humans | 72 | 2026 | 16832 | 1.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2015 | 352 | 1.540 |
Why?
|
| Counseling | 10 | 2020 | 170 | 1.530 |
Why?
|
| Aspirin | 3 | 2021 | 61 | 1.490 |
Why?
|
| Gynecological Examination | 6 | 2017 | 6 | 1.470 |
Why?
|
| Obstetrics | 9 | 2020 | 20 | 1.460 |
Why?
|
| Contraception | 9 | 2016 | 24 | 1.290 |
Why?
|
| Gynecology | 8 | 2020 | 21 | 1.270 |
Why?
|
| Abortifacient Agents, Steroidal | 2 | 2026 | 2 | 1.210 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2023 | 158 | 1.190 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2016 | 290 | 1.120 |
Why?
|
| Practice Guidelines as Topic | 8 | 2024 | 311 | 1.070 |
Why?
|
| Adult | 38 | 2026 | 7255 | 1.040 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 553 | 1.020 |
Why?
|
| Qualitative Research | 4 | 2024 | 288 | 1.000 |
Why?
|
| Sexual Behavior | 6 | 2020 | 112 | 0.990 |
Why?
|
| Preventive Health Services | 9 | 2021 | 142 | 0.980 |
Why?
|
| Sexually Transmitted Diseases | 6 | 2020 | 53 | 0.940 |
Why?
|
| Behavior Therapy | 4 | 2021 | 121 | 0.940 |
Why?
|
| Attitude of Health Personnel | 6 | 2015 | 197 | 0.900 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 55 | 0.900 |
Why?
|
| Women's Health | 8 | 2016 | 178 | 0.880 |
Why?
|
| Abortion Applicants | 1 | 2024 | 1 | 0.860 |
Why?
|
| Progestins | 2 | 2023 | 24 | 0.800 |
Why?
|
| Blood Pressure Determination | 1 | 2023 | 57 | 0.780 |
Why?
|
| Mammography | 1 | 2024 | 141 | 0.770 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 40 | 0.760 |
Why?
|
| Desogestrel | 1 | 2022 | 2 | 0.760 |
Why?
|
| Intrauterine Devices | 5 | 2026 | 12 | 0.740 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2026 | 317 | 0.710 |
Why?
|
| Pharmacies | 1 | 2021 | 9 | 0.680 |
Why?
|
| Pharmacy | 1 | 2021 | 12 | 0.680 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 57 | 0.670 |
Why?
|
| United States | 22 | 2024 | 3858 | 0.670 |
Why?
|
| Contraception Behavior | 8 | 2016 | 16 | 0.660 |
Why?
|
| Pharmaceutical Services | 1 | 2021 | 37 | 0.660 |
Why?
|
| Self Concept | 2 | 2011 | 36 | 0.650 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 130 | 0.640 |
Why?
|
| Tobacco Use Cessation | 2 | 2021 | 16 | 0.640 |
Why?
|
| Prenatal Care | 3 | 2020 | 123 | 0.630 |
Why?
|
| Advisory Committees | 6 | 2023 | 112 | 0.620 |
Why?
|
| Genital Diseases, Female | 3 | 2017 | 7 | 0.620 |
Why?
|
| Patient Satisfaction | 6 | 2014 | 186 | 0.610 |
Why?
|
| Bacteriuria | 1 | 2019 | 1 | 0.610 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 53 | 0.600 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 22 | 0.590 |
Why?
|
| Hepatitis B | 1 | 2019 | 43 | 0.580 |
Why?
|
| Physicians | 3 | 2014 | 114 | 0.540 |
Why?
|
| Middle Aged | 21 | 2024 | 7515 | 0.540 |
Why?
|
| Nepal | 6 | 2015 | 6 | 0.520 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 49 | 0.520 |
Why?
|
| Health Education | 2 | 2015 | 79 | 0.500 |
Why?
|
| Norpregnadienes | 2 | 2026 | 2 | 0.490 |
Why?
|
| Levonorgestrel | 2 | 2026 | 7 | 0.490 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 913 | 0.490 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 160 | 0.490 |
Why?
|
| Depression | 2 | 2011 | 479 | 0.480 |
Why?
|
| Physician-Patient Relations | 2 | 2010 | 169 | 0.480 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 16 | 0.470 |
Why?
|
| Primary Health Care | 7 | 2021 | 693 | 0.470 |
Why?
|
| Young Adult | 9 | 2020 | 2456 | 0.470 |
Why?
|
| Male | 18 | 2021 | 9556 | 0.450 |
Why?
|
| Health Care Surveys | 9 | 2014 | 201 | 0.450 |
Why?
|
| Intrauterine Devices, Copper | 2 | 2026 | 6 | 0.440 |
Why?
|
| Family Planning Services | 5 | 2017 | 20 | 0.440 |
Why?
|
| Patient Care Team | 1 | 2015 | 98 | 0.430 |
Why?
|
| Condoms | 5 | 2014 | 32 | 0.430 |
Why?
|
| Contraceptive Agents, Female | 4 | 2026 | 13 | 0.420 |
Why?
|
| Estrogens | 3 | 2023 | 55 | 0.420 |
Why?
|
| Health Personnel | 2 | 2012 | 132 | 0.400 |
Why?
|
| Communication | 2 | 2016 | 183 | 0.390 |
Why?
|
| Thrombosis | 2 | 2023 | 16 | 0.380 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2024 | 11 | 0.380 |
Why?
|
| Pregnancy in Adolescence | 2 | 2010 | 5 | 0.380 |
Why?
|
| Women's Health Services | 4 | 2014 | 12 | 0.380 |
Why?
|
| Adolescent | 14 | 2021 | 3464 | 0.370 |
Why?
|
| Odds Ratio | 5 | 2020 | 569 | 0.370 |
Why?
|
| Premature Birth | 3 | 2021 | 133 | 0.360 |
Why?
|
| Contraceptive Agents | 3 | 2023 | 6 | 0.360 |
Why?
|
| Family Practice | 3 | 2012 | 40 | 0.350 |
Why?
|
| Interviews as Topic | 6 | 2015 | 305 | 0.320 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 3 | 0.320 |
Why?
|
| Risk Factors | 5 | 2021 | 3108 | 0.320 |
Why?
|
| Directive Counseling | 1 | 2010 | 21 | 0.320 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 160 | 0.310 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 98 | 0.310 |
Why?
|
| Attitude to Health | 1 | 2010 | 142 | 0.300 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 185 | 0.300 |
Why?
|
| Sex Factors | 1 | 2011 | 560 | 0.290 |
Why?
|
| Surveys and Questionnaires | 9 | 2016 | 1204 | 0.290 |
Why?
|
| Referral and Consultation | 1 | 2010 | 147 | 0.290 |
Why?
|
| Infant, Newborn | 3 | 2023 | 828 | 0.280 |
Why?
|
| Pregnancy Rate | 2 | 2026 | 7 | 0.270 |
Why?
|
| Professional-Patient Relations | 3 | 2017 | 45 | 0.260 |
Why?
|
| Risk Reduction Behavior | 2 | 2020 | 97 | 0.260 |
Why?
|
| Benchmarking | 2 | 2004 | 32 | 0.250 |
Why?
|
| Aged | 8 | 2024 | 5901 | 0.250 |
Why?
|
| Quality Assurance, Health Care | 3 | 2004 | 117 | 0.250 |
Why?
|
| Smoking Cessation | 3 | 2021 | 140 | 0.250 |
Why?
|
| Contraceptives, Postcoital | 1 | 2026 | 1 | 0.250 |
Why?
|
| Pandemics | 3 | 2023 | 289 | 0.240 |
Why?
|
| Vaginal Smears | 2 | 2018 | 47 | 0.230 |
Why?
|
| HIV Infections | 6 | 2007 | 708 | 0.230 |
Why?
|
| Age Factors | 3 | 2020 | 814 | 0.230 |
Why?
|
| Quality of Life | 2 | 2023 | 477 | 0.220 |
Why?
|
| Travel | 1 | 2024 | 10 | 0.220 |
Why?
|
| Physicians, Women | 1 | 2004 | 10 | 0.210 |
Why?
|
| Ultrasonography, Mammary | 1 | 2024 | 4 | 0.210 |
Why?
|
| Anesthetics, Local | 1 | 2024 | 6 | 0.210 |
Why?
|
| Fractures, Bone | 1 | 2024 | 92 | 0.200 |
Why?
|
| Pain Management | 1 | 2024 | 56 | 0.200 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 262 | 0.190 |
Why?
|
| Ovulation | 1 | 2022 | 5 | 0.190 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2022 | 5 | 0.190 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2021 | 27 | 0.190 |
Why?
|
| Sex | 1 | 2021 | 2 | 0.180 |
Why?
|
| Perinatal Death | 1 | 2021 | 2 | 0.180 |
Why?
|
| Postpartum Hemorrhage | 1 | 2021 | 4 | 0.180 |
Why?
|
| Gender Identity | 1 | 2021 | 33 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2002 | 71 | 0.170 |
Why?
|
| Adolescent Health | 1 | 2021 | 6 | 0.170 |
Why?
|
| Regression Analysis | 3 | 2014 | 261 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 55 | 0.170 |
Why?
|
| Data Collection | 3 | 2010 | 223 | 0.170 |
Why?
|
| Child Health | 1 | 2021 | 41 | 0.170 |
Why?
|
| Tobacco Use Disorder | 1 | 2021 | 32 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2021 | 1186 | 0.160 |
Why?
|
| Nurse Practitioners | 2 | 2013 | 18 | 0.160 |
Why?
|
| Pyelonephritis | 1 | 2019 | 3 | 0.150 |
Why?
|
| Infant | 1 | 2023 | 1212 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2019 | 30 | 0.150 |
Why?
|
| Microbiota | 1 | 2019 | 10 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 16 | 0.150 |
Why?
|
| Hispanic Americans | 3 | 2006 | 350 | 0.150 |
Why?
|
| Pregnancy, Unwanted | 4 | 2014 | 7 | 0.150 |
Why?
|
| Time Factors | 2 | 2014 | 989 | 0.150 |
Why?
|
| Case Management | 1 | 2019 | 27 | 0.150 |
Why?
|
| Logistic Models | 3 | 2014 | 796 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2022 | 292 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 353 | 0.140 |
Why?
|
| Papillomaviridae | 1 | 2018 | 58 | 0.140 |
Why?
|
| CA-125 Antigen | 1 | 2018 | 6 | 0.140 |
Why?
|
| False Positive Reactions | 1 | 2018 | 25 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 23 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 32 | 0.130 |
Why?
|
| Quality of Health Care | 2 | 2020 | 249 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 145 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 48 | 0.130 |
Why?
|
| Telemedicine | 1 | 2020 | 190 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 291 | 0.120 |
Why?
|
| Confidence Intervals | 3 | 2006 | 207 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2018 | 1047 | 0.120 |
Why?
|
| Risk | 1 | 2017 | 453 | 0.120 |
Why?
|
| Grounded Theory | 1 | 2015 | 7 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 87 | 0.110 |
Why?
|
| Smoking Prevention | 1 | 2015 | 32 | 0.110 |
Why?
|
| Culture | 2 | 2014 | 28 | 0.110 |
Why?
|
| Morbidity | 2 | 2013 | 56 | 0.110 |
Why?
|
| Contraceptives, Oral | 1 | 2014 | 22 | 0.110 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 11 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2014 | 60 | 0.100 |
Why?
|
| Reproductive Health | 1 | 2014 | 10 | 0.100 |
Why?
|
| Aftercare | 1 | 2014 | 46 | 0.100 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2013 | 4 | 0.100 |
Why?
|
| National Health Programs | 2 | 2004 | 9 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 489 | 0.100 |
Why?
|
| Age Distribution | 2 | 2005 | 221 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 24 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 105 | 0.090 |
Why?
|
| Human papillomavirus 16 | 1 | 2012 | 7 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2014 | 205 | 0.090 |
Why?
|
| Mortality | 1 | 2013 | 116 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2012 | 48 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2010 | 92 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2013 | 136 | 0.090 |
Why?
|
| Perception | 1 | 2012 | 53 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2463 | 0.090 |
Why?
|
| Sex Determination Analysis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hospitals, Public | 1 | 2011 | 2 | 0.090 |
Why?
|
| Advanced Practice Nursing | 1 | 2010 | 1 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2010 | 11 | 0.080 |
Why?
|
| Continental Population Groups | 2 | 2009 | 255 | 0.080 |
Why?
|
| Causality | 1 | 2010 | 32 | 0.080 |
Why?
|
| Sexual Partners | 3 | 2007 | 34 | 0.080 |
Why?
|
| Power (Psychology) | 1 | 2010 | 3 | 0.080 |
Why?
|
| Tape Recording | 1 | 2010 | 5 | 0.080 |
Why?
|
| Sexual Abstinence | 1 | 2010 | 2 | 0.080 |
Why?
|
| Empathy | 1 | 2010 | 8 | 0.080 |
Why?
|
| Health Surveys | 1 | 2011 | 226 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2010 | 21 | 0.080 |
Why?
|
| Vasectomy | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mental Health | 1 | 2011 | 161 | 0.080 |
Why?
|
| Health Services Research | 3 | 2007 | 180 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 1887 | 0.070 |
Why?
|
| Los Angeles | 2 | 2006 | 139 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 516 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2014 | 2396 | 0.070 |
Why?
|
| Safety | 2 | 2005 | 43 | 0.070 |
Why?
|
| Health Behavior | 1 | 2010 | 332 | 0.070 |
Why?
|
| Michigan | 2 | 2004 | 26 | 0.060 |
Why?
|
| Couples Therapy | 1 | 2007 | 1 | 0.060 |
Why?
|
| Health Status | 2 | 2007 | 256 | 0.060 |
Why?
|
| Office Visits | 1 | 2007 | 78 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 2 | 2004 | 126 | 0.060 |
Why?
|
| Child | 2 | 2023 | 2433 | 0.060 |
Why?
|
| Nurse Midwives | 1 | 2005 | 2 | 0.060 |
Why?
|
| Physician Assistants | 1 | 2005 | 6 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2005 | 62 | 0.060 |
Why?
|
| Income | 1 | 2005 | 81 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2009 | 571 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1233 | 0.050 |
Why?
|
| Poverty | 3 | 2013 | 167 | 0.050 |
Why?
|
| Pennsylvania | 1 | 2004 | 23 | 0.050 |
Why?
|
| North Carolina | 1 | 2004 | 35 | 0.050 |
Why?
|
| Carticaine | 1 | 2024 | 1 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2024 | 4 | 0.050 |
Why?
|
| Lidocaine | 1 | 2024 | 5 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2024 | 3 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2004 | 13 | 0.050 |
Why?
|
| Contraceptive Devices, Female | 1 | 2004 | 1 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 653 | 0.050 |
Why?
|
| Managed Care Programs | 2 | 2002 | 275 | 0.050 |
Why?
|
| Pain | 1 | 2024 | 65 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2024 | 45 | 0.050 |
Why?
|
| Copper | 1 | 2023 | 4 | 0.050 |
Why?
|
| Steroids | 1 | 2023 | 12 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2023 | 2 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2004 | 242 | 0.050 |
Why?
|
| Baltimore | 1 | 2002 | 12 | 0.050 |
Why?
|
| Seasons | 1 | 2022 | 114 | 0.050 |
Why?
|
| Linear Models | 1 | 2002 | 187 | 0.040 |
Why?
|
| Education | 1 | 2021 | 14 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 346 | 0.040 |
Why?
|
| Transgender Persons | 1 | 2021 | 44 | 0.040 |
Why?
|
| Public Health | 2 | 2016 | 80 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 103 | 0.040 |
Why?
|
| Pregnancy, Unplanned | 2 | 2013 | 7 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2018 | 5 | 0.040 |
Why?
|
| Papanicolaou Test | 1 | 2018 | 36 | 0.030 |
Why?
|
| Process Assessment (Health Care) | 1 | 2018 | 22 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 34 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 816 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 114 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2016 | 2 | 0.030 |
Why?
|
| Varenicline | 1 | 2015 | 12 | 0.030 |
Why?
|
| Bupropion | 1 | 2015 | 9 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2015 | 15 | 0.030 |
Why?
|
| Drug Implants | 1 | 2014 | 2 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2015 | 155 | 0.030 |
Why?
|
| Women | 1 | 2013 | 11 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 44 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 60 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 657 | 0.020 |
Why?
|
| Contraindications | 1 | 2012 | 13 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 107 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1229 | 0.020 |
Why?
|
| Population Growth | 1 | 2009 | 1 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 163 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 4 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2006 | 112 | 0.010 |
Why?
|
| Federal Government | 1 | 2005 | 11 | 0.010 |
Why?
|
| Government Regulation | 1 | 2005 | 6 | 0.010 |
Why?
|
| State Government | 1 | 2005 | 13 | 0.010 |
Why?
|
| Violence | 1 | 2005 | 32 | 0.010 |
Why?
|
| Safe Sex | 1 | 2004 | 3 | 0.010 |
Why?
|
| Forecasting | 1 | 2005 | 67 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 84 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 120 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 99 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 45 | 0.010 |
Why?
|
| Northwestern United States | 1 | 2004 | 53 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 1098 | 0.010 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2002 | 7 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 164 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 2004 | 358 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 319 | 0.010 |
Why?
|
| California | 1 | 2005 | 2244 | 0.010 |
Why?
|